Knee Osteoarthritis Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx

DelveInsight's "Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Knee Osteoarthritis, historical and forecasted epidemiology as well as the Knee Osteoarthritis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Knee Osteoarthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Knee Osteoarthritis Market Forecast
https://www.delveinsight.com/sample-request/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Knee Osteoarthritis Market Report:
• The Knee Osteoarthritis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• On March 2021, For the treatment of knee OA, Seikagaku received manufacturing and marketing authorisation in Japan for JOYCLU
• The use of intra-articular hyaluronan was conditionally recommended in patients with knee OA in all groups in accordance with the most recent Osteoarthritis Research Society International (OARSI) recommendations, which were released in 2019
• It was determined that 47,874,567 people in the seven major markets had symptomatic knee OA as of 2021. With 17,660,391 cases, the United States had the highest prevalence of the disease in 2021. The EU4 and the UK contributed for 19,946,245 cases
• According to the data, a higher proportion of mild instances of knee OA were seen in the 7MM, with moderate occurrences of knee OA following in 2021. The most common types of knee OA in the US in 2021 were mild (7,373,858) and moderate (6,562,734), respectively
• In 2021, there were 10,267,932 instances of Knee OA with symptoms in Japan. In 2021, there were 6,407,189 female cases and 4,312,531 male cases of knee OA overall
• Key Knee Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, TissueTech, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, Winston Laboratories, Ensol Bioscience, LG Life Sciences, Huons Co., Ltd., Sun Pharma, Daewon Pharmaceutical Co., Ltd., and others
• Key Knee Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin/RTX-GRT7039, Lorecivivint, X0002, Amniofix, TTAX03, Ampion, ReNu, Cartistem, JointStem, Civamide, E1K 1,200, LBSA0103, Humia inj, MM-II, Pelubiprofen CR, and others
• The Knee Osteoarthritis epidemiology based on gender analyzed that females are most commonly affected than males in case of Knee Osteoarthritis (OA)
• The Knee Osteoarthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Knee Osteoarthritis pipeline products will significantly revolutionize the Knee Osteoarthritis market dynamics.

Knee Osteoarthritis Overview
Osteoarthritis (OA), commonly referred to as degenerative joint disease, affects the knee and is primarily brought on by wear-and-tear and the progressive loss of articular cartilage. It can be classified into two types: primary and secondary, and it is more prevalent in elderly people.

Get a Free sample for the Knee Osteoarthritis Market Report
https://www.delveinsight.com/report-store/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Knee Osteoarthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Knee Osteoarthritis Epidemiology Segmentation:
The Knee Osteoarthritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Knee Osteoarthritis
• Prevalent Cases of Knee Osteoarthritis by severity
• Gender-specific Prevalence of Knee Osteoarthritis
• Diagnosed Cases of Episodic and Chronic Knee Osteoarthritis

Download the report to understand which factors are driving Knee Osteoarthritis epidemiology trends @
https://www.delveinsight.com/sample-request/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Knee Osteoarthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Knee Osteoarthritis market or expected to get launched during the study period. The analysis covers Knee Osteoarthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Knee Osteoarthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Knee Osteoarthritis Therapies and Key Companies
• CNTX-4975: Centrexion Therapeutics
• TLC599: Taiwan Liposome Company
• Resiniferatoxin/RTX-GRT7039: Grünenthal
• Lorecivivint: Biosplice Therapeutics
• X0002: Techfields
• Amniofix: MiMedx
• TTAX03: TissueTech
• Ampion: Ampio Pharmaceuticals
• ReNu: Organogenesis
• Cartistem: Medipost
• JointStem: Naturecell
• Civamide: Winston Laboratories
• E1K 1,200: Ensol Bioscience
• LBSA0103: LG Life Sciences
• Humia inj.: Huons Co., Ltd.
• MM-II: Sun Pharma
• Pelubiprofen CR: Daewon Pharmaceutical Co., Ltd.

Discover more about therapies set to grab major Knee Osteoarthritis market share @ https://www.delveinsight.com/sample-request/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Knee Osteoarthritis Market Strength
• Now companies are investing heavily in developing disease modifying therapies for the treatment of Knee Osteoarthritis, which will fulfill a major unmet need.
• Many key players are developing cell therapies for Knee Osteoarthritis, which are in various stages of development. These therapies, if approved, may provide a better treatment options as it can slow disease progression and may possibly cure the disease

Knee Osteoarthritis Market Opportunities
• For the treatment of Knee Osteoarthritis, usage of opioids can be seen. The majority of patients/ physicians are eagerly waiting for non-opioids options and key players can target this lucrative segment of the market, while others are already developing therapies for the same

Scope of the Knee Osteoarthritis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Knee Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, TissueTech, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, Winston Laboratories, Ensol Bioscience, LG Life Sciences, Huons Co., Ltd., Sun Pharma, Daewon Pharmaceutical Co., Ltd., and others
• Key Knee Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin/RTX-GRT7039, Lorecivivint, X0002, Amniofix, TTAX03, Ampion, ReNu, Cartistem, JointStem, Civamide, E1K 1,200, LBSA0103, Humia inj, MM-II, Pelubiprofen CR, and others
• Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies
• Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Knee Osteoarthritis Unmet Needs, KOL's views, Analyst's views, Knee Osteoarthritis Market Access and Reimbursement

To know more about Knee Osteoarthritis companies working in the treatment market, visit @
https://www.delveinsight.com/sample-request/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Knee Osteoarthritis Market Report Introduction
2. Executive Summary for Knee Osteoarthritis
3. SWOT analysis of Knee Osteoarthritis
4. Knee Osteoarthritis Patient Share (%) Overview at a Glance
5. Knee Osteoarthritis Market Overview at a Glance
6. Knee Osteoarthritis Disease Background and Overview
7. Knee Osteoarthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Knee Osteoarthritis
9. Knee Osteoarthritis Current Treatment and Medical Practices
10. Knee Osteoarthritis Unmet Needs
11. Knee Osteoarthritis Emerging Therapies
12. Knee Osteoarthritis Market Outlook
13. Country-Wise Knee Osteoarthritis Market Analysis (2019-2032)
14. Knee Osteoarthritis Market Access and Reimbursement of Therapies
15. Knee Osteoarthritis Market Drivers
16. Knee Osteoarthritis Market Barriers
17. Knee Osteoarthritis Appendix
18. Knee Osteoarthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Knee Osteoarthritis Pipeline https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Knee Osteoarthritis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Knee Osteoarthritis market. A detailed picture of the Knee Osteoarthritis pipeline landscape is provided, which includes the disease overview and Knee Osteoarthritis treatment guidelines.

Latest Reports by DelveInsight
Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.